Georgia Erbez

2020 - Harpoon Therapeutics

In 2020, Georgia Erbez earned a total compensation of $1M as Chief Financial Officer at Harpoon Therapeutics, a 90% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$156,000
Option Awards$468,734
Salary$390,000
Other$8,550
Total$1,023,284

Erbez received $468.7K in option awards, accounting for 46% of the total pay in 2020.

Erbez also received $156K in non-equity incentive plan, $390K in salary and $8.6K in other compensation.

Rankings

In 2020, Georgia Erbez's compensation ranked 8,544th out of 13,090 executives tracked by ExecPay. In other words, Erbez earned more than 34.7% of executives.

ClassificationRankingPercentile
All
8,544
out of 13,090
35th
Division
Manufacturing
3,636
out of 5,621
35th
Major group
Chemicals And Allied Products
1,470
out of 2,254
35th
Industry group
Drugs
1,281
out of 1,954
34th
Industry
Biological Products, Except Diagnostic Substances
300
out of 411
27th
Source: SEC filing on March 24, 2021.

Erbez's colleagues

We found two more compensation records of executives who worked with Georgia Erbez at Harpoon Therapeutics in 2020.

2020

Gerald McMahon

Harpoon Therapeutics

Chief Executive Officer

2020

Natalie Sacks

Harpoon Therapeutics

Chief Medical Officer

News

You may also like